For her unparalleled leadership as a patient advocate, including through the AACR’s Scientist↔Survivor Program®; her dedication to improving the patient experience through innovative clinical trial designs, including ISPY2, TAPUR and the Alliance for Clinical Trials; and for efforts to ensure that the patient voice is included in research and trial design, accelerating patient access to new treatments and drastically improving their quality of life and overall survivorship.
To learn more, please visit the press release.